S I D E B A R
Format
Items per page
Sort by

Download:

Choose Destination

Search results

Items: 1 to 100 of 2358

VariationLocationGene(s)Condition(s)Clinical significance
(Last reviewed)
Review status
1.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Feb 26, 2008)
no assertion criteria provided
2.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(May 11, 2006)
no assertion criteria provided
3.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Nov 7, 2006)
no assertion criteria provided
4.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Nov 3, 2006)
no assertion criteria provided
5.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Jan 21, 2010)
no assertion criteria provided
6.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Sep 21, 2012)
no assertion criteria provided
7.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(May 1, 2012)
no assertion criteria provided
8.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Jan 6, 2006)
no assertion criteria provided
9.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(May 1, 2012)
no assertion criteria provided
10.
BRCA1Breast-ovarian cancer, familial 1Benign
(May 1, 2012)
no assertion criteria provided
11.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(May 1, 2012)
no assertion criteria provided
12.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Aug 29, 2007)
no assertion criteria provided
13.
BRCA2Breast-ovarian cancer, familial 2Benign
(May 1, 2012)
no assertion criteria provided
14.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(May 1, 2012)
no assertion criteria provided
15.
BRCA2Breast-ovarian cancer, familial 2Likely benign
(May 1, 2012)
no assertion criteria provided
16.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Feb 6, 2006)
no assertion criteria provided
17.
BRCA2Breast-ovarian cancer, familial 2Likely benign
(May 1, 2012)
no assertion criteria provided
18.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(May 1, 2012)
no assertion criteria provided
19.
BRCA2Breast-ovarian cancer, familial 2Benign
(May 1, 2012)
no assertion criteria provided
20.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(May 1, 2012)
no assertion criteria provided
21.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Dec 12, 2008)
no assertion criteria provided
22.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Jun 11, 2007)
no assertion criteria provided
23.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Jan 17, 2007)
no assertion criteria provided
24.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Nov 29, 2006)
no assertion criteria provided
25.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Oct 4, 2007)
no assertion criteria provided
26.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Jan 28, 2008)
no assertion criteria provided
27.
BRCA1Breast-ovarian cancer, familial 1Likely pathogenic
(Jun 11, 2010)
no assertion criteria provided
28.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Jul 30, 2013)
no assertion criteria provided
29.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Oct 27, 2007)
no assertion criteria provided
30.
BRCA1Breast-ovarian cancer, familial 1Uncertain significance
(May 5, 2006)
no assertion criteria provided
31.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(May 1, 2012)
no assertion criteria provided
32.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Nov 30, 2007)
no assertion criteria provided
33.
BRCA1Breast-ovarian cancer, familial 1Benign
(Jan 25, 2012)
no assertion criteria provided
34.
BRCA1Breast-ovarian cancer, familial 1Uncertain significance
(Aug 23, 2007)
no assertion criteria provided
35.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Mar 16, 2011)
no assertion criteria provided
36.
BRCA1Breast-ovarian cancer, familial 1Benign
(May 1, 2012)
no assertion criteria provided
37.
BRCA1Breast-ovarian cancer, familial 1Uncertain significance
(Mar 29, 2006)
no assertion criteria provided
38.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Jul 5, 2007)
no assertion criteria provided
39.
BRCA1Breast-ovarian cancer, familial 1Benign
(Feb 12, 2010)
no assertion criteria provided
40.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(May 7, 2007)
no assertion criteria provided
41.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Jun 28, 2006)
no assertion criteria provided
42.
BRCA1Breast-ovarian cancer, familial 1Likely benign
(Jun 12, 2008)
no assertion criteria provided
43.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(Mar 8, 2006)
no assertion criteria provided
44.
BRCA1Breast-ovarian cancer, familial 1Uncertain significance
(Nov 26, 2007)
no assertion criteria provided
45.
BRCA1Breast-ovarian cancer, familial 1Pathogenic
(May 22, 2008)
no assertion criteria provided
46.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Oct 3, 2007)
no assertion criteria provided
47.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Jul 28, 2010)
no assertion criteria provided
48.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(May 1, 2012)
no assertion criteria provided
49.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(May 1, 2012)
no assertion criteria provided
50.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Jan 14, 2008)
no assertion criteria provided
51.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Jun 22, 2006)
no assertion criteria provided
52.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Apr 11, 2007)
no assertion criteria provided
53.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Aug 3, 2007)
no assertion criteria provided
54.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Jul 7, 2006)
no assertion criteria provided
55.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Feb 21, 2006)
no assertion criteria provided
56.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Mar 28, 2012)
no assertion criteria provided
57.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Aug 31, 2006)
no assertion criteria provided
58.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Jun 7, 2007)
no assertion criteria provided
59.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Apr 26, 2006)
no assertion criteria provided
60.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Jan 2, 2007)
no assertion criteria provided
61.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Feb 15, 2007)
no assertion criteria provided
62.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(May 1, 2012)
no assertion criteria provided
63.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(May 10, 2006)
no assertion criteria provided
64.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(May 1, 2012)
no assertion criteria provided
65.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Jan 25, 2006)
no assertion criteria provided
66.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Mar 23, 2007)
no assertion criteria provided
67.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Dec 11, 2007)
no assertion criteria provided
68.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(May 14, 2009)
no assertion criteria provided
69.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(May 30, 2013)
no assertion criteria provided
70.
BRCA2Breast-ovarian cancer, familial 2Benign
(May 17, 2011)
no assertion criteria provided
71.
BRCA2Breast-ovarian cancer, familial 2Benign
(Oct 23, 2007)
no assertion criteria provided
72.
BRCA2Breast-ovarian cancer, familial 2Benign
(May 26, 2010)
no assertion criteria provided
73.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Apr 16, 2007)
no assertion criteria provided
74.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Sep 14, 2007)
no assertion criteria provided
75.
BRCA2Breast-ovarian cancer, familial 2Benign
(Sep 1, 2007)
no assertion criteria provided
76.
BRCA2Breast-ovarian cancer, familial 2Benign
(Jan 20, 2010)
no assertion criteria provided
77.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Nov 28, 2007)
no assertion criteria provided
78.
BRCA2Breast-ovarian cancer, familial 2Benign
(Oct 17, 2006)
no assertion criteria provided
79.
BRCA2Breast-ovarian cancer, familial 2Uncertain significance
(Aug 9, 2007)
no assertion criteria provided
80.
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Feb 26, 2012)
no assertion criteria provided
81.
BRCA2Breast-ovarian cancer, familial 2Benign
(Mar 20, 2008)
no assertion criteria provided
82.
GRCh37:
Chr13:32890539
GRCh38:
Chr13:32316402
BRCA2Breast-ovarian cancer, familial 2Likely benign
(Nov 28, 2011)
no assertion criteria provided
83.
GRCh37:
Chr13:32890545
GRCh38:
Chr13:32316408
BRCA2Breast-ovarian cancer, familial 2Likely benign
(Apr 20, 2012)
no assertion criteria provided
84.
GRCh37:
Chr13:32890547-32890549
GRCh38:
Chr13:32316410-32316412
BRCA2Breast-ovarian cancer, familial 2, not specified, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Feb 27, 2018)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr13:32890572
GRCh38:
Chr13:32316435
BRCA2Familial cancer of breast, Breast-ovarian cancer, familial 2, Fanconi anemia,
Hereditary breast and ovarian cancer syndrome, not specified, Hereditary cancer-predisposing syndrome
Benign
(Jan 12, 2015)
reviewed by expert panel
86.
GRCh37:
Chr13:32890574
GRCh38:
Chr13:32316437
BRCA2Breast-ovarian cancer, familial 2Likely benign
(Aug 30, 2010)
no assertion criteria provided
87.
GRCh37:
Chr13:32890583
GRCh38:
Chr13:32316446
BRCA2Breast-ovarian cancer, familial 2, Hereditary breast and ovarian cancer syndrome, not specified,
Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Nov 16, 2015)
criteria provided, conflicting interpretations
88.
GRCh37:
Chr13:32890589
GRCh38:
Chr13:32316452
BRCA2Breast-ovarian cancer, familial 2, Hereditary breast and ovarian cancer syndrome, not specified,
not provided, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Nov 20, 2017)
criteria provided, conflicting interpretations
89.
GRCh37:
Chr13:32890595
GRCh38:
Chr13:32316458
BRCA2Breast-ovarian cancer, familial 2, Hereditary breast and ovarian cancer syndromeUncertain significance
(Jun 11, 2014)
no assertion criteria provided
90.
GRCh37:
Chr13:32890600
GRCh38:
Chr13:32316463
BRCA2Breast-ovarian cancer, familial 2, Hereditary breast and ovarian cancer syndrome, Hereditary cancer-predisposing syndrome
Pathogenic
(Mar 14, 2018)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr13:32890600
GRCh38:
Chr13:32316463
BRCA2Breast-ovarian cancer, familial 2, Hereditary cancer-predisposing syndromePathogenic
(Mar 16, 2017)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr13:32890600
GRCh38:
Chr13:32316463
BRCA2Breast-ovarian cancer, familial 2, Hereditary breast and ovarian cancer syndromePathogenic
(Jan 31, 2014)
no assertion criteria provided
93.
GRCh37:
Chr13:32890614-32890615
GRCh38:
Chr13:32316477-32316478
BRCA2Breast-ovarian cancer, familial 2, not providedPathogenic
(Sep 8, 2016)
reviewed by expert panel
94.
GRCh37:
Chr13:32890619-32890620
GRCh38:
Chr13:32316482-32316483
BRCA2Breast-ovarian cancer, familial 2, Hereditary breast and ovarian cancer syndromePathogenic
(Sep 8, 2016)
reviewed by expert panel
95.
GRCh37:
Chr13:32890623
GRCh38:
Chr13:32316486
BRCA2Breast-ovarian cancer, familial 2, Hereditary breast and ovarian cancer syndrome, not provided,
Hereditary cancer-predisposing syndrome
Pathogenic
(Apr 22, 2016)
reviewed by expert panel
96.
GRCh37:
Chr13:32890631
GRCh38:
Chr13:32316494
BRCA2Breast-ovarian cancer, familial 2, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(May 1, 2018)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr13:32890633
GRCh38:
Chr13:32316496
BRCA2Breast-ovarian cancer, familial 2, Hereditary breast and ovarian cancer syndrome, not provided
Pathogenic
(Sep 8, 2016)
reviewed by expert panel
98.
GRCh37:
Chr13:32890645-32890647
GRCh38:
Chr13:32316508-32316510
BRCA2Breast-ovarian cancer, familial 2Pathogenic
(Oct 22, 2012)
no assertion criteria provided
99.
GRCh37:
Chr13:32890650
GRCh38:
Chr13:32316513
BRCA2Breast-ovarian cancer, familial 2, Hereditary breast and ovarian cancer syndrome, not specified,
Hereditary cancer-predisposing syndrome
Benign
(Aug 10, 2015)
reviewed by expert panel
100.
GRCh37:
Chr13:32890656
GRCh38:
Chr13:32316519
BRCA2Breast-ovarian cancer, familial 2, Hereditary cancer-predisposing syndromeUncertain significance
(Apr 21, 2016)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by

Download:

Choose Destination
Support Center